TB-500 protocol considerations Reported dosing in the research literature: Starting dose: 500 mcg daily, subcutaneous injection Titration: Increase by 100 to 150 mcg every two weeks as tolerated Target dose: 750 to 1000 mcg daily by weeks five through twelve Weekly total: Approximately 5 mg per week at full dose Cycle length: Eight to twelve weeks, with optional extension to sixteen weeks TB-500 is typically administered once daily via subcutaneous injection, with consistent timing and systematic site rotation
10.3109/09513590.2012.650768 127 WangY.LiD.XuX.QianR.ZhangY.HuangY.et al (2016)
Results are gradual
Produced through a fermentation process Supports antioxidant function Featuring Setria L-glutathione Product Details Produced through a fermentation process Supports antioxidant function Featuring Setria L-glutathione Healthy Origins Setria L-Glutathione Reduced is a naturally derived tripeptide compound that contains three amino acids: L-cysteine, L-glutamic acid and glycine
Under the same conditions, the hemodynamic response measured by blood oxygen level-dependent (BOLD) functional MRI, a primary technique for visualizing brain activity by detecting local changes in blood oxygenation and flow that correlate with neural activation, was completely prevented in all MCT2-downregulated rats
Registration is free and easy